Cytosorbents Corp SEC filings CTSO
Cytosorbents Corp has 977 filings in SEC EDGAR's recent list, going back to Mar 29, 2004. Its latest annual report, Form ARS, was filed on Jun 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jun 25, 2026 | — |
| DEF 14A | Proxy statement | Jun 25, 2026 | Aug 13, 2026 |
| PRE 14A | Preliminary proxy statement | Jun 11, 2026 | Jun 11, 2026 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 12, 2025 |
| DEFA14A | Additional proxy material | Apr 19, 2024 | — |
| DEF 14A | Proxy statement | Apr 19, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Jun 6, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2022 | — |
| DEF 14A | Proxy statement | Apr 22, 2022 | Jun 7, 2022 |
| DEFA14A | Additional proxy material | Apr 19, 2021 | — |
| DEF 14A | Proxy statement | Apr 19, 2021 | Jun 1, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 20, 2020 | Jun 2, 2020 |
| DEFA14A | Additional proxy material | Apr 22, 2019 | — |
| DEF 14A | Proxy statement | Apr 22, 2019 | Jun 4, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 5, 2019 | Jun 4, 2019 |
| DEFA14A | Additional proxy material | Apr 25, 2018 | — |
| DEF 14A | Proxy statement | Apr 25, 2018 | Jun 5, 2018 |
| DEFA14A | Additional proxy material | Apr 27, 2017 | — |
| DEF 14A | Proxy statement | Apr 27, 2017 | Jun 6, 2017 |
| DEFA14A | Additional proxy material | Apr 25, 2016 | — |
| DEF 14A | Proxy statement | Apr 25, 2016 | Jun 7, 2016 |
| DEFA14A | Additional proxy material | Apr 22, 2015 | — |
| DEF 14A | Proxy statement | Apr 22, 2015 | Jun 2, 2015 |
| DEFA14A | Additional proxy material | Nov 14, 2014 | — |
| DEFA14A | Additional proxy material | Nov 6, 2014 | — |
| DEF 14A | Proxy statement | Nov 6, 2014 | Nov 6, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2014 | Oct 23, 2014 |
| DEF 14C | Information statement | Mar 25, 2013 | Mar 25, 2013 |
| PRE 14C | Form pre 14c | Mar 12, 2013 | Mar 12, 2013 |
| DEF 14C | Information statement | Nov 18, 2008 | Nov 18, 2008 |
| PRE 14C | Filing | Nov 6, 2008 | Nov 6, 2008 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CTSO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Princeton, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1175151
- Former names
- MedaSorb Technologies CORP (until Apr 15, 2010); GILDER ENTERPRISES INC (until Jul 24, 2006)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.